These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 25785660

  • 1. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Mar 18; 2015(3):CD001533. PubMed ID: 25785660
    [Abstract] [Full Text] [Related]

  • 2. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2024 Aug 22; 8(8):CD001533. PubMed ID: 39171624
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Samuel SM, Willis NS, Craig JC, Hobson EM.
    Cochrane Database Syst Rev; 2020 Aug 31; 2020(8):CD001533. PubMed ID: 35659203
    [Abstract] [Full Text] [Related]

  • 4. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2003 Aug 31; (1):CD001533. PubMed ID: 12535410
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2004 Aug 31; (2):CD001533. PubMed ID: 15106158
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD001533. PubMed ID: 17943754
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2001 Oct 17; (2):CD001533. PubMed ID: 11405997
    [Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD001533. PubMed ID: 15674881
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2000 Jan 25; (4):CD001533. PubMed ID: 11034723
    [Abstract] [Full Text] [Related]

  • 10. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
    [Abstract] [Full Text] [Related]

  • 11. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2013 Oct 29; (10):CD002290. PubMed ID: 24166716
    [Abstract] [Full Text] [Related]

  • 12. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
    Health Technol Assess; 2019 May 29; 23(26):1-108. PubMed ID: 31156083
    [Abstract] [Full Text] [Related]

  • 13. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 14. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Wong SC, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
    [Abstract] [Full Text] [Related]

  • 15. Interventions for minimal change disease in adults with nephrotic syndrome.
    Azukaitis K, Palmer SC, Strippoli GF, Hodson EM.
    Cochrane Database Syst Rev; 2022 Mar 01; 3(3):CD001537. PubMed ID: 35230699
    [Abstract] [Full Text] [Related]

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 17. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A, Hodson E, Willis N, Craig J.
    Cochrane Database Syst Rev; 2001 Feb 01; (4):CD002290. PubMed ID: 11687155
    [Abstract] [Full Text] [Related]

  • 18. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002290. PubMed ID: 15846634
    [Abstract] [Full Text] [Related]

  • 19. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002290. PubMed ID: 18254005
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY.
    Cochrane Database Syst Rev; 2016 May 05; 2016(5):CD003725. PubMed ID: 27149418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.